Example: Heart Attack

Search clinical trials for: Girls Can...Move!

Total 6088 results

NCT05373147

Recruiting

αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors

Solid Tumor
NCT05164042

Recruiting

Allogeneic CD19 CAR-T Cells for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia (CAR-T)

Refractory Leukemia | Relapse Leukemia
NCT04594135

Recruiting

Anti-CD5 CAR T Cells for Relapsed/Refractory T Cell Malignancies (CD5CAR-T)

T-cell Acute Lymphoblastic Leukemia | T-cell Non-Hodgkin Lymphoma
NCT04550663

Not yet recruiting

NKG2D CAR-T(KD-025) in the Treatment of Relapsed or Refractory NKG2DL+ Tumors

Glioma | Hepatocellular Carcinoma | Colorectal Cancer | Solid Tumor
NCT03356782

Recruiting

Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas

Sarcoma | Ewing Sarcoma | Osteoid Sarcoma
NCT07364487

Withdrawn

This is an Open-Label Study to Assess the Safety and Efficacy of GC012F in Patients With Multiple Sclerosis

Multiple Sclerosis
NCT06827782

Enrolling by invitation

Cord Blood-derived CAR-NK Cells Targeting CD19 for Refractory/Relapsed Central Nervous System Lymphoma

Refractory/Recurrent Central Nervous System Lymphoma
NCT03628612

Enrolling by invitation

Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells

Multiple Myeloma | DLBCL | T Cell Lymphoma | Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy | ALL, Adult and Pediatric
NCT03968458

Completed

Effect of Exercise Timing on Energy Intake and Appetite in Adolescents With Obesity: the TIMEX 3 Study (TIMEX 3)

Pediatric Obesity
NCT05887986

Completed

Management of Dyspnea: Use of Hand Held Fan

Lung Cancer
NCT03931070

Completed

The Effect of Ramelteon on Delirium and Sleep in Patients Admitted to the ICU

Delirium
NCT05571540

Withdrawn

Anti-CD19 Universal CAR-T Cells for r/r CD19+ B-ALL

B-cell Acute Lymphoblastic Leukemia | B-ALL
NCT02439216

Completed

Phase 1/2 Study in Boys With Duchenne Muscular Dystrophy (MoveDMD®)

Muscular Dystrophy, Duchenne
NCT04176913

Terminated

Study of LUCAR-20S in Patients With R/R NHL

Follicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma
NCT03545815

Unknown

Study of CRISPR-Cas9 Mediated PD-1 and TCR Gene-knocked Out Mesothelin-directed CAR-T Cells in Patients With Mesothelin Positive Multiple Solid Tumors.

Solid Tumor, Adult
NCT03150979

Completed

Effects of a Provision of a Cane After Stroke

Stroke
NCT03089060

Completed

Silicone Finger Cap ("Silikonfingerling")

Finger Injuries
NCT03932955

Unknown

MC-19PD1 CAR-T in Relapsed or Refractory B Cell Lymphoma

Lymphoma
NCT03692637

Unknown

Study of Anti-Mesothelin Car NK Cells in Epithelial Ovarian Cancer

Epithelial Ovarian Cancer
NCT02085473

Completed

A Study of Tralokinumab When Delivered Subcutaneously at Different Flow Rates to Healthy Volunteers

Asthma | Healthy Subjects or Volunteers
NCT03559764

Unknown

Study of BCMA CAR-T in Multiple Myeloma

Relapsed and Refractory Multiple Myeloma
NCT01211548

Completed

Coronary CT Angiography in Aneurysms Repaired With Open or Endovascular Approach (CARE)

Complex Aortic Surgery
NCT02601482

Unknown

Optimization of Interval-training in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2
NCT00974506

Completed

Pilot Study: Complementary Therapies in Geriatric Patients

Geriatric Patients
NCT01509274

Unknown

Treatment of Plantar Fasciitis With Injection af Platelet-rich Plasma Into the Origin of the Plantar Fascia

Plantar Fasciitis
NCT01301300

Unknown

Evaluating Central Line Hub Contamination Using a Novel Capping Device

Catheter-related Bloodstream Infection Due to Central Venous Catheter
NCT00735332

Terminated

Efficacy Study of TLN-232 in Patients With Recurring Metastatic Melanoma

Melanoma
NCT07308171

Not yet recruiting

Nasal Airflow to Modulate Dyspnea in Tracheostomized Patients (MODUS)

Ventilated Patients
NCT05206071

Recruiting

Clinical Study of SL19+22 CAR-T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma

Non-hodgkin's Lymphoma
NCT05259566

Active, not recruiting

Potential Impact of Menthol Ban in Cigarettes and E-cigarettes

Tobacco Smoking
NCT05046067

Completed

Feasibility Study of Anatomical Modeling for Image Guided Thoracic Surgery

Lung Neoplasm
NCT02672501

Unknown

A Study to Assess CD19-targeted Immunotherapy T Cells in Patients With Relapsed or Refractory CD19+ B Cell Leukemia

Leukemia, B-Cell
NCT07535138

Not yet recruiting

Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy

Membranous Nephropathy | IgA Nephropathy (IgAN) | Lupus Nephritis (LN)
NCT07515937

Recruiting

Occlusal Assessment of Pediatric Mandibular Fractures Managed by 3D-Printed Acrylic Occlusal Cap Splint: A Case Series

Pediatric Mandibular Fracture
NCT07485504

Not yet recruiting

Safety and Efficacy of DIT101 in Relapsed or Refractory Hematologic Malignancies

Relapsed or Refractory Hematologic Malignancies
NCT07394205

Not yet recruiting

Clinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic Cancer

Advanced Gastric and Pancreatic Cancer
NCT07359014

Recruiting

Novel CD19/BCMA Dual-Targeted CAR-T Cell Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma

Relapse Multiple Myeloma
NCT07303790

Recruiting

This is an Early Exploratory Study to Assess the Tolerability and Safety of GC012F in Patients With Multiple Sclerosis

Multiple Sclerosis
NCT07263906

Recruiting

Clinical Study of LILRA6 CAR-T for the Treatment of R/R Acute Myeloid Leukemia

Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia
NCT07249879

Recruiting

This Study is an Open-lable, Early Study to Evaluate the Safety, Feasibility, Cytokinetics, and Preliminary Efficacy of GC511B in DLL3+ Relapsed/Refractory Small Cell Lung Cancer.

Relapsed/Refractory Small Cell Lung Cancer
NCT07233018

Not yet recruiting

A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/ Refractory Acute Myeloid Leukemia

Relapsed/Refractory Acute Myeloid Leukemia(AML)
NCT07224568

Not yet recruiting

Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors (INTERCEPT)

Hepatocellular Carcinoma | Liposarcoma | Rhabdomyosarcoma | Yolk Sac Tumor | Liver Cell Carcinoma | Solid Tumor (Excluding CNS)
NCT07181720

Recruiting

CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors

Cervical Cancer | Ovarian Cancer | Thymic Carcinoma | Lung Cancer | Renal Cell Carcinoma (RCC) | Anaplastic Thyroid Carcinomas
NCT07179692

Recruiting

CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors

Gastric Cancer | Esophageal Cancer | Lung Cancer | Rectal Cancer | Colon Cancer | Pancreas Cancer
NCT07148050

Recruiting

Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells (IMPACT)

Hepatocellular Carcinoma | Liposarcoma | Rhabdomyosarcoma | Wilms Tumor | Hepatoblastoma | Malignant Rhabdoid Tumor | Yolk Sac Tumor | Liver Cell Carcinoma | Solid Tumor (Excluding CNS) | Embryonal Sarcoma of Liver
NCT06759181

Recruiting

Safety and Efficacy of Anti-BCMA/FcRL5 CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma (R/R MM)

Multiple Myeloma
NCT06791681

Recruiting

A Study of ESO-T01 in Treating Relapsed/ Refractory Multiple Myeloma

Relapsed/ Refractory Multiple Myeloma
NCT06842589

Recruiting

Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cell Therapy in Patients With MDR-SRNS

CAR-T Cell Therapy | Multi-Drug Resistant Nephrotic Syndrome
NCT06567626

Recruiting

Decision Support Tool for Revascularisation Options in Coronary Artery Disease (DECIDE-CAD)

Coronary Artery Disease
NCT06518876

Not yet recruiting

A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory POEMS Syndrome

POEMS Syndrome

Search clinical trials for: Girls Can...Move!

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations